These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 527626)

  • 1. Tumor inhibition by chlorambucil covalently linked to antitumor globulin.
    Tai J; Blair AH; Ghose T
    Eur J Cancer (1965); 1979 Nov; 15(11):1357-63. PubMed ID: 527626
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocytosis of chlorambucil-bound anti-tumor globulin following "capping" in EL4 lymphoma cells.
    Guclu A; Tai J; Ghose T
    Immunol Commun; 1975; 4(3):229-42. PubMed ID: 1100518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of an AKR lymphoma by antibody and chlorambucil.
    Ghose T; Guclu A; Tai J
    J Natl Cancer Inst; 1975 Dec; 55(6):1353-7. PubMed ID: 1107575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of chlorambucil with antitumor globulins and its effect on drug and antibody activities.
    Guclu A; Ghose T; Tai J; Mammen M
    Eur J Cancer (1965); 1976 Feb; 12(2):95-100. PubMed ID: 4329
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of monoclonal antibodies to a tumor--associated antigen by spontaneous cell fusion.
    Subbiah K; Ananthanarayanan M
    Indian J Cancer; 2000 Mar; 37(1):15-22. PubMed ID: 11261231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. II. Increased expression of tumor-associated antigens on subline cells recognized by serologic and transplantation methods.
    Fuji H; Mihich E; Pressman D
    J Natl Cancer Inst; 1979 Jun; 62(6):1503-10. PubMed ID: 286122
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies as carriers of anticancer agents.
    Rubens RD
    Lancet; 1974 Mar; 1(7856):498-9. PubMed ID: 4131895
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids.
    Klein G; Klein E
    Eur J Cancer (1965); 1979 Apr; 15(4):551-7. PubMed ID: 436915
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 13. Ag-bearing liposomes engrafted with peptides that interact with CD11c/CD18 induce potent Ag-specific and antitumor immunity.
    Faham A; Altin JG
    Int J Cancer; 2011 Sep; 129(6):1391-403. PubMed ID: 21128234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effect of drugs and tumor-specific antibodies in protection against a mouse lymphoma.
    Davies DA
    Cancer Res; 1974 Nov; 34(11):3040-3. PubMed ID: 4418406
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune reactivity to tumor antigens in leukemia and lymphoma.
    Leventhal BG; Mirro J; Yarbro GS
    Semin Hematol; 1978 Apr; 15(2):157-79. PubMed ID: 148730
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumours can act as adjuvants for humoral immunity.
    Brown DM; Fisher TL; Wei C; Frelinger JG; Lord EM
    Immunology; 2001 Apr; 102(4):486-97. PubMed ID: 11328383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N; King CA; Vitetta ES; Stevenson FK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
    Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of tumor antigens.
    Herberman RB; Campbell DA; Oldham RK; Bonnard GD; Ting CC; Holden HT; Glaser M; Djeu J; Oehler R
    Ann N Y Acad Sci; 1976; 276():26-44. PubMed ID: 194517
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics of the immune response to tumor-specific cell-surface antigens.
    Abeyounis CJ; Zaleski MB; Milgrom F
    Transplant Proc; 1979 Mar; 11(1):1066-8. PubMed ID: 109957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.